Pharmaceutical manufacturer
Appears in 1 story
Settled for $400 million
The U.S. District Court for the District of Connecticut approved a plan to distribute settlement funds from generic drug manufacturers accused of conspiring to inflate prices. Consumers who bought certain generic prescription drugs in the United States between May 2009 and December 2019 can now file claims for compensation.
Updated 2 hours ago
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
